For IPO Boutique's "scale of 1 to 5" BUY rating on Nephrogenex, Inc., and our comprehensive analysis, click "Buy Market Research".
About Nephrogenex, Inc. (adapted from Nephrogenex, Inc. prospectus): They are a pharmaceutical company focused on the development of therapeutics to treat kidney disease, an area of significant unmet medical need.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "NRX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
Used our Comprehensive Single Promo Advisory and want more?
